1147-D Preclinical characterization of a novel claudin 18.2 targeting-ISAC with robust potency and acceptable safety profile

• Matthew Zhou,
• William Mallet,
• Romas Kudirka,
• Han K Kim,
• Justin Monnier,
• Chi-Ling Fu,
• Jennifer E Melrose,
• Hung Dao,
• Paul D Ponath,
• Katelynn A McEachin,
• David T Omstead,
• Cindy Kreder,
• Stefan Chun,
• Ying Yueh Lee,
• Rachel Grgich,
• Tracey J Lin,
• Joshua A Walker,
• Karla A Henning,
• Shelley E Ackerman,
• Diane Carrera,
• Steven J Chapin,
• Dowdy Jackson,
• Changshou Gao,
• Michael N Alonso

Affiliations

Matthew Zhou

1Bolt Biotherapeutics, Redwood City, CA, USA

William Mallet

1Bolt Biotherapeutics, Redwood City, CA, USA

Romas Kudirka

1Bolt Biotherapeutics, Redwood City, CA, USA

Han K Kim

1Bolt Biotherapeutics, Redwood City, CA, USA

Justin Monnier

1Bolt Biotherapeutics, Redwood City, CA, USA

Chi-Ling Fu

1Bolt Biotherapeutics, Redwood City, CA, USA

Jennifer E Melrose

1Bolt Biotherapeutics, Redwood City, CA, USA

Hung Dao

1Bolt Biotherapeutics, Redwood City, CA, USA

Paul D Ponath

1Bolt Biotherapeutics, Redwood City, CA, USA

Katelynn A McEachin

1Bolt Biotherapeutics, Redwood City, CA, USA

David T Omstead

1Bolt Biotherapeutics, Redwood City, CA, USA

Cindy Kreder

1Bolt Biotherapeutics, Redwood City, CA, USA

Stefan Chun

1Bolt Biotherapeutics, Redwood City, CA, USA

Ying Yueh Lee

1Bolt Biotherapeutics, Redwood City, CA, USA

Rachel Grgich

1Bolt Biotherapeutics, Redwood City, CA, USA

Tracey J Lin

1Bolt Biotherapeutics, Redwood City, CA, USA

Joshua A Walker

1Bolt Biotherapeutics, Redwood City, CA, USA

Karla A Henning

1Bolt Biotherapeutics, Redwood City, CA, USA

Shelley E Ackerman

1Bolt Biotherapeutics, Redwood City, CA, USA

Diane Carrera

1Bolt Biotherapeutics, Redwood City, CA, USA

Steven J Chapin

1Bolt Biotherapeutics, Redwood City, CA, USA

Dowdy Jackson

2Innovent Biologics USA, Rockville, MD, USA

Changshou Gao

2Innovent Biologics USA, Rockville, MD, USA

Michael N Alonso

1Bolt Biotherapeutics, Redwood City, CA, USA